SCHEMBL7944461

SCHEMBL7944461

COc1ccc(Cl)cc1-c1nn(-c2ccc(C(F)(F)F)cc2)c(=O)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
HPGD P15428 3/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
PRNP P04156 1/20 0.42
PPARG P37231 1/20 0.42
MAPK10 P53779 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPBWR1 P48145 2/20 0.42
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756323 0.83 TMPRSS4 (0.44) MAPTKMT2AMEN1CYP2C9
SCHEMBL5753851 0.80 MAPT (0.49) MAPTHPGDKMT2ASMN1; SMN2KDM4E
SCHEMBL7957472 0.80 MAPT (0.45) MAPTHPGDKMT2ASMN1; SMN2MEN1
SCHEMBL7957104 0.78 ATM (0.46) NPSR1NPBWR1KCNQ3KCNQ2KCNQ4
SCHEMBL7944175 0.72 KMT2A (0.43) MAPTKMT2ANPBWR1CYP2C9MCHR1
SCHEMBL7950922 0.72 CYP2C9 (0.47) MAPTHPGDKMT2ASMN1; SMN2MEN1
SCHEMBL7141017 0.72 ABHD6 (0.43) MAPTHPGDKMT2ASMN1; SMN2KDM4E
SCHEMBL7952869 0.72 ABHD6 (0.43) MAPTKMT2AKCNQ3KCNQ2KCNQ4
SCHEMBL7951068 0.71 ABHD6 (0.42) MAPTKCNQ3KCNQ2KCNQ4KCNMA1
SCHEMBL7954633 0.70 NR1I2 (0.47) HPGDKMT2ASMN1; SMN2MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271249-B1 Diphenyl imidazoles as potassium channel modulators BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6077861-A MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-20 US disclosed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US disclosed